NCT04326426View on ClinicalTrials.gov

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 13, 2020

Primary Completion Date

August 1, 2020

Study Completion Date

August 31, 2020

Conditions
Coronavirus Infection
Interventions
DRUG

Tradipitant

Neurokinin-1 antagonist

DRUG

Placebo

Matching placebo

Trial Locations (1)

10075

Lenox Hill Hospital Northwell Health, New York

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY